Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

By Peter H. Jones, M. Davidson, E. Stein, H. Bays, J. Mckenney, Elinor Miller, V. Cain, J. Blasetto. American Journal of Cardiology, 2003

1,304 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. (2004, background): “For example, even with high-dose statins (34) or LDL-lowering drug combinations (35,36), LDL-C reductions 50% often cannot be achieved.”
Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. (2007, background): “Rosuvastatin is effective at lowering LDL-C concentrations.(11,12) In addition, rosuvastatin, like other statins, has favorable effects on other components of the lipid and lipoprotein profile, such as raising high-density lipoprotein cholesterol (HDL-C) and reducing levels of total cholesterol and ”